151 related articles for article (PubMed ID: 17458504)
1. Taurolidine: a novel anti-neoplastic agent induces apoptosis of osteosarcoma cell lines.
Walters DK; Muff R; Langsam B; Gruber P; Born W; Fuchs B
Invest New Drugs; 2007 Aug; 25(4):305-12. PubMed ID: 17458504
[TBL] [Abstract][Full Text] [Related]
2. The effects of taurolidine alone and in combination with doxorubicin or carboplatin in canine osteosarcoma in vitro.
Marley K; Helfand SC; Edris WA; Mata JE; Gitelman AI; Medlock J; Séguin B
BMC Vet Res; 2013 Jan; 9():15. PubMed ID: 23331343
[TBL] [Abstract][Full Text] [Related]
3. Induction of reactive oxygen intermediates-dependent programmed cell death in human malignant ex vivo glioma cells and inhibition of the vascular endothelial growth factor production by taurolidine.
Rodak R; Kubota H; Ishihara H; Eugster HP; Könü D; Möhler H; Yonekawa Y; Frei K
J Neurosurg; 2005 Jun; 102(6):1055-68. PubMed ID: 16028765
[TBL] [Abstract][Full Text] [Related]
4. The effects of taurolidine, a novel antineoplastic agent, on human malignant mesothelioma.
Nici L; Monfils B; Calabresi P
Clin Cancer Res; 2004 Nov; 10(22):7655-61. PubMed ID: 15569998
[TBL] [Abstract][Full Text] [Related]
5. The antineoplastic antibiotic taurolidine promotes lung and liver metastasis in two syngeneic osteosarcoma mouse models and exhibits severe liver toxicity.
Arlt MJ; Walters DK; Banke IJ; Steinmann P; Puskas GJ; Bertz J; Rentsch KM; Ehrensperger F; Born W; Fuchs B
Int J Cancer; 2012 Sep; 131(5):E804-12. PubMed ID: 22120774
[TBL] [Abstract][Full Text] [Related]
6. Taurolidine: cytotoxic and mechanistic evaluation of a novel antineoplastic agent.
Calabresi P; Goulette FA; Darnowski JW
Cancer Res; 2001 Sep; 61(18):6816-21. PubMed ID: 11559556
[TBL] [Abstract][Full Text] [Related]
7. Taurolidine induces apoptosis of murine melanoma cells in vitro and in vivo by modulation of the Bcl-2 family proteins.
Sun BS; Wang JH; Liu LL; Gong SL; Redmond HP
J Surg Oncol; 2007 Sep; 96(3):241-8. PubMed ID: 17469118
[TBL] [Abstract][Full Text] [Related]
8. [In vitro effect of taurolidine on squamous cell carcinoma in the oral cavity].
Petrovic L; Schlegel KA; Ries J; Park J; Diebel E; Schultze-Mosgau S; Wiltfang J
Mund Kiefer Gesichtschir; 2003 Mar; 7(2):102-7. PubMed ID: 12664255
[TBL] [Abstract][Full Text] [Related]
9. Dual functionality of the antimicrobial agent taurolidine which demonstrates effective anti-tumor properties in pediatric neuroblastoma.
Swift L; Zhang C; Kovalchuk O; Boklan J; Trippett T; Narendran A
Invest New Drugs; 2020 Jun; 38(3):690-699. PubMed ID: 31264069
[TBL] [Abstract][Full Text] [Related]
10. Taurolidine specifically inhibits growth of neuroblastoma cell lines in vitro.
Luckert C; Eschenburg G; Roth B; Appl B; Reinshagen K; Bergholz R
J Pediatr Hematol Oncol; 2014 May; 36(4):e219-23. PubMed ID: 24762556
[TBL] [Abstract][Full Text] [Related]
11. Taurolidine: preclinical evaluation of a novel, highly selective, agent for bone marrow purging.
Ribizzi I; Darnowski JW; Goulette FA; Akhtar MS; Chatterjee D; Calabresi P
Bone Marrow Transplant; 2002 Feb; 29(4):313-9. PubMed ID: 11896428
[TBL] [Abstract][Full Text] [Related]
12. The antibacterial drug taurolidine induces apoptosis by a mitochondrial cytochrome c-dependent mechanism.
Han Z; Ribbizi I; Pantazis P; Wyche J; Darnowski J; Calabresi P
Anticancer Res; 2002; 22(4):1959-64. PubMed ID: 12174870
[TBL] [Abstract][Full Text] [Related]
13. Divergent effects of taurolidine as potential anti-neoplastic agent: inhibition of bladder carcinoma cells in vitro and promotion of bladder tumor in vivo.
Abramjuk C; Bueschges M; Schnorr J; Jung K; Staack A; Lein M
Oncol Rep; 2009 Aug; 22(2):409-14. PubMed ID: 19578784
[TBL] [Abstract][Full Text] [Related]
14. Taurolidine and povidone-iodine induce different types of cell death in malignant pleural mesothelioma.
Opitz I; Sigrist B; Hillinger S; Lardinois D; Stahel R; Weder W; Hopkins-Donaldson S
Lung Cancer; 2007 Jun; 56(3):327-36. PubMed ID: 17383050
[TBL] [Abstract][Full Text] [Related]
15. Comparative analysis of cell death induction by Taurolidine in different malignant human cancer cell lines.
Chromik AM; Daigeler A; Bulut D; Flier A; May C; Harati K; Roschinsky J; Sülberg D; Ritter PR; Mittelkötter U; Hahn SA; Uhl W
J Exp Clin Cancer Res; 2010 Mar; 29(1):21. PubMed ID: 20205945
[TBL] [Abstract][Full Text] [Related]
16. Impact of taurolidine on the growth of CC531 coloncarcinoma cells in vitro and in a laparoscopic animal model in rats.
Nestler G; Schulz HU; Schubert D; Krüger S; Lippert H; Pross M
Surg Endosc; 2005 Feb; 19(2):280-4. PubMed ID: 15870965
[TBL] [Abstract][Full Text] [Related]
17.
Byer B; Schlein LJ; Rose B; Séguin B
Can J Vet Res; 2020 Apr; 84(2):115-123. PubMed ID: 32255906
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of Fas-ligand-mediated programmed cell death by taurolidine.
Stendel R; Scheurer L; Stoltenburg-Didinger G; Brock M; Möhler H
Anticancer Res; 2003; 23(3B):2309-14. PubMed ID: 12894508
[TBL] [Abstract][Full Text] [Related]
19. Mechanistic and antineoplastic evaluation of taurolidine in the DU145 model of human prostate cancer.
Darnowski JW; Goulette FA; Cousens LP; Chatterjee D; Calabresi P
Cancer Chemother Pharmacol; 2004 Sep; 54(3):249-58. PubMed ID: 15173956
[TBL] [Abstract][Full Text] [Related]
20. The tumor-suppressive reagent taurolidine is an inhibitor of protein biosynthesis.
Braumann C; Henke W; Jacobi CA; Dubiel W
Int J Cancer; 2004 Nov; 112(2):225-30. PubMed ID: 15352034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
